Marcus Schultze‐Mosgau

867 total citations
17 papers, 624 citations indexed

About

Marcus Schultze‐Mosgau is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Materials Chemistry. According to data from OpenAlex, Marcus Schultze‐Mosgau has authored 17 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Materials Chemistry. Recurrent topics in Marcus Schultze‐Mosgau's work include Lanthanide and Transition Metal Complexes (5 papers), Medical Imaging Techniques and Applications (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Marcus Schultze‐Mosgau is often cited by papers focused on Lanthanide and Transition Metal Complexes (5 papers), Medical Imaging Techniques and Applications (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Marcus Schultze‐Mosgau collaborates with scholars based in Germany, United States and United Kingdom. Marcus Schultze‐Mosgau's co-authors include Josy Breuer, Peter Hauff, Wolfgang Ebert, Simone Gschwend, Regina Reszka, Osama Sabri, Beate Rohde, Georg Becker, Henryk Barthel and Cornelia Reininger and has published in prestigious journals such as Radiology, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Marcus Schultze‐Mosgau

17 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Schultze‐Mosgau Germany 13 186 146 134 130 118 17 624
David Y. Huang United States 15 149 0.8× 24 0.2× 181 1.4× 154 1.2× 41 0.3× 25 788
Nahzli Dilek France 19 43 0.2× 28 0.2× 67 0.5× 255 2.0× 72 0.6× 27 1.1k
Abdesslem Khiat Canada 15 454 2.4× 29 0.2× 27 0.2× 135 1.0× 408 3.5× 32 953
N Kosaka Japan 15 943 5.1× 72 0.5× 107 0.8× 110 0.8× 48 0.4× 30 1.6k
Yoshinao Abe Japan 19 502 2.7× 25 0.2× 59 0.4× 137 1.1× 41 0.3× 63 1.1k
Qing Yuan China 20 322 1.7× 17 0.1× 31 0.2× 159 1.2× 31 0.3× 86 922
Stefan Zurbruegg Switzerland 15 105 0.6× 13 0.1× 143 1.1× 116 0.9× 63 0.5× 22 573
Mark Battle Spain 11 225 1.2× 18 0.1× 129 1.0× 89 0.7× 16 0.1× 27 477
Kyung Ho Han South Korea 15 61 0.3× 12 0.1× 106 0.8× 320 2.5× 28 0.2× 34 762
Nathalie Perek France 16 138 0.7× 12 0.1× 84 0.6× 169 1.3× 31 0.3× 42 656

Countries citing papers authored by Marcus Schultze‐Mosgau

Since Specialization
Citations

This map shows the geographic impact of Marcus Schultze‐Mosgau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Schultze‐Mosgau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Schultze‐Mosgau more than expected).

Fields of papers citing papers by Marcus Schultze‐Mosgau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Schultze‐Mosgau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Schultze‐Mosgau. The network helps show where Marcus Schultze‐Mosgau may publish in the future.

Co-authorship network of co-authors of Marcus Schultze‐Mosgau

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Schultze‐Mosgau. A scholar is included among the top collaborators of Marcus Schultze‐Mosgau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Schultze‐Mosgau. Marcus Schultze‐Mosgau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kunze, Christian, Hans‐Joachim Mentzel, Rajesh Krishnamurthy, et al.. (2015). Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations. Investigative Radiology. 51(1). 50–57. 21 indexed citations
2.
Senda, Michio, Masahiro Sasaki, Tomohiko Yamane, et al.. (2014). Ethnic comparison of pharmacokinetics of 18F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects. European Journal of Nuclear Medicine and Molecular Imaging. 42(1). 89–96. 8 indexed citations
3.
Varrone, Andrea, Anton Forsberg, Akihiro Takano, et al.. (2013). In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 921–931. 64 indexed citations
4.
Niederalt, Christoph, Thomas Wendl, Lars Kuepfer, et al.. (2013). Development of a Physiologically Based Computational Kidney Model to Describe the Renal Excretion of Hydrophilic Agents in Rats. Frontiers in Physiology. 3. 494–494. 11 indexed citations
5.
Takano, Akihiro, Fredrik Piehl, Jan Hillert, et al.. (2013). In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. EJNMMI Research. 3(1). 30–30. 63 indexed citations
6.
Becker, Georg, Masanori Ichise, Henryk Barthel, et al.. (2013). PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains. Journal of Nuclear Medicine. 54(5). 723–731. 89 indexed citations
7.
Reif, Stefanie, Marcus Schultze‐Mosgau, & Gerd Sutter. (2012). From Adults to Children. Pediatric Drugs. 14(3). 189–200. 6 indexed citations
8.
Huppertz, Alexander, Josy Breuer, Lueder Fels, et al.. (2011). Evaluation of possible drug–drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP). Journal of Magnetic Resonance Imaging. 33(2). 409–416. 22 indexed citations
9.
Gschwend, Simone, Wolfgang Ebert, Marcus Schultze‐Mosgau, & Josy Breuer. (2011). Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment. Investigative Radiology. 46(9). 556–566. 76 indexed citations
10.
Patt, Marianne, Andreas Schildan, Henryk Barthel, et al.. (2010). Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial. Journal of Radioanalytical and Nuclear Chemistry. 284(3). 557–562. 28 indexed citations
11.
12.
Hahn, Gabriele, Ina Sorge, Bernd Gruhn, et al.. (2009). Pharmacokinetics and Safety of Gadobutrol-Enhanced Magnetic Resonance Imaging in Pediatric Patients. Investigative Radiology. 44(12). 776–783. 41 indexed citations
13.
Hauff, Peter, Regina Reszka, Marcus Schultze‐Mosgau, et al.. (2005). Evaluation of Gas-filled Microparticles and Sonoporation as Gene Delivery System: Feasibility Study in Rodent Tumor Models. Radiology. 236(2). 572–578. 92 indexed citations
14.
Hauff, Peter, et al.. (2002). Pharmaceutical Evaluation of Gas-Filled Microparticles as Gene Delivery System. Pharmaceutical Research. 19(3). 250–257. 46 indexed citations
15.
Boos, Joachim, et al.. (1998). Augmentation of 1-β-d-Arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs. European Journal of Cancer. 34(6). 895–901. 12 indexed citations
16.
Schultze‐Mosgau, Marcus, et al.. (1998). Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. European Journal of Cancer. 34(9). 1425–1431. 24 indexed citations
17.
Courage, C, et al.. (1997). Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine. International Journal of Cancer. 73(5). 763–768. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Y. Huang Breakdown of academic impact, for papers by Nahzli Dilek Breakdown of academic impact, for papers by Abdesslem Khiat Breakdown of academic impact, for papers by N Kosaka Breakdown of academic impact, for papers by Yoshinao Abe Breakdown of academic impact, for papers by Qing Yuan Breakdown of academic impact, for papers by Stefan Zurbruegg Breakdown of academic impact, for papers by Mark Battle Breakdown of academic impact, for papers by Kyung Ho Han Breakdown of academic impact, for papers by Nathalie Perek
Rankless by CCL
2026